Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-21-007613
Filing Date
2021-06-07
Accepted
2021-06-07 17:21:02
Documents
13

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2097155
2 filename2.htm EX-10.6 223377
3 GRAPHIC g99471g01k65.jpg GRAPHIC 66963
4 GRAPHIC g99471g09q91.jpg GRAPHIC 99381
5 GRAPHIC g99471g10h99.jpg GRAPHIC 113030
6 GRAPHIC g99471g15s86.jpg GRAPHIC 86705
7 GRAPHIC g99471g16s84.jpg GRAPHIC 55385
8 GRAPHIC g99471g29j64.jpg GRAPHIC 193040
9 GRAPHIC g99471g31l69.jpg GRAPHIC 129576
10 GRAPHIC g99471g35h67.jpg GRAPHIC 139356
11 GRAPHIC g99471g78e05.jpg GRAPHIC 77862
12 GRAPHIC g99471g87q67.jpg GRAPHIC 45834
13 GRAPHIC g99471g89t00.jpg GRAPHIC 129140
  Complete submission text file 0000950123-21-007613.txt   3869653
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Holdings, LLC (Filer) CIK: 0001739410 (see all company filings)

EIN.: 823919910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-04734 | Film No.: 211000421
SIC: 2834 Pharmaceutical Preparations